Citation Impact
Citing Papers
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
2009
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
Infection, inflammation, height, and longevity
2005 Standout
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 StandoutScience
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
2004
The role of short chain fatty acids in appetite regulation and energy homeostasis
2015
An Increased Flux through the Glucose 6-Phosphate Pool in Enterocytes Delays Glucose Absorption in Fxr–/– Mice
2009
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Adipose tissue as a buffer for daily lipid flux
2002
mTOR Signaling in Growth Control and Disease
2012 Standout
Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice
2010
Impact of a Resistant Dextrin with a Prolonged Oxidation Pattern on Day-Long Ghrelin Profile
2011
Alterations in Adipose Tissue during Critical Illness
2010
Liver fat and lipid oxidation in humans
2009
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
2001 StandoutNature
Human fat cell lipolysis: Biochemistry, regulation and clinical role
2005
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
2007 Standout
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
2016
Autophagy regulates lipid metabolism
2009 StandoutNature
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
Cushing's syndrome
2015 Standout
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
2008
Studies of insulin resistance in congenital generalized lipodystrophy*
1996
Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes
2004
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
2005
Prebiotics and the Health Benefits of Fiber: Current Regulatory Status, Future Research, and Goals,
2012
Glucose transporter 4 and insulin receptor substrate–1 messenger RNA expression in omental and subcutaneous adipose tissue in women
2009
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes
2010
Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
2007 Nature
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
2009
Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver Disease
2011
Thiazolidinediones and the liver in humans
2009
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
2014 StandoutNature
Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion
2004
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
2007
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels
2008
Human aquaporin adipose (AQPap) gene
2002
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes
2010
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
Metabolomic and Mass Isotopomer Analysis of Liver Gluconeogenesis and Citric Acid Cycle
2008
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance
2009
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Proteolytic and lipolytic responses to starvation
2006
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study
2005
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
2004
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
2004
AKT/PKB Signaling: Navigating the Network
2017 Standout
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
SREBP-1c Transcription Factor and Lipid Homeostasis: Clinical Perspective
2007
Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members
2005
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
Use of stable isotopically labeled tracers for studies of metabolic kinetics: An overview
1997
Insulin signalling mechanisms for triacylglycerol storage
2013
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Metformin Prevents the Development of Acute Lipid-Induced Insulin Resistance in the Rat Through Altered Hepatic Signaling Mechanisms
2004
Causes and Metabolic Consequences of Fatty Liver
2008
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Diagnostic Evaluation of Cushing’s Syndrome
1988
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Coordinated Regulation of Fat-Specific and Liver-Specific Glycerol Channels, Aquaporin Adipose and Aquaporin 9
2002
A Role of the Bile Salt Receptor FXR in Atherosclerosis
2010
Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction
2000
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
2007
Fatty acid cycling in the fasting rat
2000
De Novo Lipogenesis Products and Endogenous Lipokines
2016
Minireview: Lipid Droplets in Lipogenesis and Lipolysis
2008
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
2002
Fatty Liver
2007
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Fiber and Prebiotics: Mechanisms and Health Benefits
2013 Standout
Frontiers, Opportunities, and Challenges in Biochemical and Chemical Catalysis of CO2 Fixation
2013 Standout
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Aquaglyceroporin AQP9: Solute permeation and metabolic control of expression in liver
2003 StandoutNobel
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
2010
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Diabetic Autonomic Neuropathy
2003 Standout
Sparse production but preferential incorporation of recently produced naïve T cells in the human peripheral pool
2008
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue
2001
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Rat Small Intestine Is an Insulin-Sensitive Gluconeogenic Organ
2001
Progression of Aortic Dilatation and the Benefit of Long-Term β-Adrenergic Blockade in Marfan's Syndrome
1994
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
Autonomic neuropathy: its diagnosis and prognosis
1986
Mechanism by which metformin reduces glucose production in type 2 diabetes.
2000
Structure, mechanism and regulation of pyruvate carboxylase
2008
Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes
2004
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
2000 Standout
Works of M. Beylot being referenced
Depot-specific differences in perilipin and hormone-sensitive lipase expression in lean and obese
2009
Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans
2003
In vivo measurement of plasma cholesterol and fatty acid synthesis with deuterated water: Determination of the average number of deuterium atoms incorporated
1996
Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease
2003
Respective role of plasma nonesterified fatty acid oxidation and total lipid oxidation in lipid-induced insulin resistance
1995
Lipolytic and Ketogenic Fluxes in Human Hyperthyroidism*
1991
Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols
1998
Determination of the 13C-Labeling Pattern of Glucose by Gas Chromatography-Mass Spectrometry
1993
Metabolism of lipids in human white adipocyte
2004
Measuring glycerol turnover, gluconeogenesis from glycerol, and total gluconeogenesis with [2-13C]glycerol: Role of the infusion-sampling mode
1996
The contribution of naturally labelled 13C fructose to glucose appearance in humans
1993
Measuring Lipogenesis and Cholesterol Synthesis in Humans with Deuterated Water: Use of Simple Gas Chromatographic/Mass Spectrometric Techniques
1997
Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans
2003
Assay of the13C and2H Mass Isotopomer Distribution of Phosphoenolpyruvate by Gas Chromatography/Mass Spectrometry
1996
Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans
2007
Assay of the Deuterium Enrichment of Water via Acetylene
1996
Determination of the 13C-Labeling Pattern of Glutamate by Gas Chromatography-Mass Spectrometry
1993
Assay of Low Deuterium Enrichment of Water by Isotopic Exchange with [U-13C3]Acetone and Gas Chromatography–Mass Spectrometry
1998
Use of a new gas chromatograph isotope ratio mass spectrometer to trace exogenous 13C labelled glucose at a very low level of enrichment in man
1990
Genes of Cholesterol Metabolism in Human Atheroma
2005
Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose
1995
The Presence of a Catalytically Inactive Form of Hormone-Sensitive Lipase Is Associated With Decreased Lipolysis in Abdominal Subcutaneous Adipose Tissue of Obese Subjects
2003
Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification
1998
Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity
2002
Assay of the concentration and stable isotope enrichment of short‐chain fatty acids by gas chromatography/mass spectrometry
1995
[Comparison between the value of urinary free cortisol and 17-hydroxycorticosteroids for the diagnosis of Cushing's syndrome].
1986
Ultrasonographic Determination of Residual Urine in Diabetic Subjects: Relationship to Neuropathy and Urinary Tract Infection
1982
Regulation of ketone body flux in septic patients
1989
Metabolic fate of an oral long-chain triglyceride load in humans
1996
Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic Patients
2002
Reduction by propranolol of urinary hydroxyproline excretion in human hyperthyroidism: A beta-receptor blockade effect or a membrane stabilizing mechanism?
1984
Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin.
1999
Metabolic studies in lipoatrophic diabetes: mechanism of hyperglycemia and evidence of resistance to insulin of lipid metabolism.
1988